4.7 Editorial Material

CA125 for Fluid Overload Monitoring A New Life for an Old Tool

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure

Kieran F. Docherty et al.

Summary: This study examined the association between baseline CA125 levels and outcomes in patients with chronic ambulatory HF with reduced ejection fraction, and investigated the effect of dapagliflozin. The results show that elevated CA125 levels are an independent predictor of the risk of worsening HF or cardiovascular death, while dapagliflozin reduces the risk of worsening HF or cardiovascular death regardless of baseline CA125 levels.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology

Julio Nunez et al.

Summary: Congestion is a significant symptom of heart failure and it varies in different types of heart failure. This article discusses the classification of heart failure based on congestion characteristics and the utility of circulating biomarkers for assessing and managing fluid overload. Further studies are needed to determine the effectiveness of biomarkers in addition to clinical evaluation, haemodynamics, and imaging.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Head-to-head comparison of contemporary heart failure risk scores

Pau Codina et al.

Summary: Multiple heart failure risk scores were compared in terms of their discrimination and overall performance, with BCN-Bio-HF calculator showing the best results in discrimination and overall performance, while MAGGIC-HF displayed the best calibration. Regular updating and recalibration of these online calculators are necessary to enhance their accuracy as heart failure management progresses rapidly.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Review Cardiac & Cardiovascular Systems

Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review

Julio Nunez et al.

Summary: CA125 is a reliable marker for congestion and inflammation in heart failure patients, strongly associated with a higher risk of adverse clinical events and potential for guiding decongestive therapy following acute heart failure events. Further research is needed to better understand its biological role and utility in clinical practice.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure

Rafael de la Espriella et al.

Summary: This study aimed to evaluate the trajectory of CA125 and NT-proBNP in patients with chronic heart failure and type 2 diabetes after initiating oral empagliflozin. The results showed a significant decrease in CA125 levels and no significant change in NT-proBNP levels following empagliflozin initiation.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Medicine, General & Internal

CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

Julio Nunez et al.

AMERICAN JOURNAL OF MEDICINE (2020)